Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome
Yaseen M. Arabi(World Health Organization), Adel Alothman(King Saud bin Abdulaziz University for Health Sciences), Fahad Al-Hameed, Jesna Jose(King Saud bin Abdulaziz University for Health Sciences), Badriah M. AlMutairi(Anna Needs Neuroblastoma Answers), Ghaleb A. Al Mekhlafi(Riyadh Armed Forces Hospital), Wail Bajhmom(King Saud bin Abdulaziz University for Health Sciences), Fatehi Elzein(Riyadh Armed Forces Hospital), Mohamed H. Azzam(Anna Needs Neuroblastoma Answers), Naif Khalaf Alharbi(Anna Needs Neuroblastoma Answers), Ziad A. Memish(Alfaisal University), Ahmad Deeb(King Saud bin Abdulaziz University for Health Sciences), Ali Al Bshabshe(King Khalid University), Abdullah M. Assiri(King Khalid University), Frederick G. Hayden(University of Virginia Health System), Asim Al Saedi(Anna Needs Neuroblastoma Answers), Abdulhadi M. Bin Eshaq(Anna Needs Neuroblastoma Answers), Sarah Al Faraj(King Saud bin Abdulaziz University for Health Sciences), Hanan H. Balkhy(World Health Organization Regional Office for the Eastern Mediterranean), Sameera Al Johani, Yasser Mandourah(Riyadh Armed Forces Hospital), Nisreen Murad Sherbeeni(Riyadh Armed Forces Hospital), Hani Jokhdar(Ministry of Health), Robert Fowler(Sunnybrook Health Science Centre), Mohamed Hussein(Humana (United States)), Ayed Y. Asiri(Prince Mohammed bin Abdulaziz Hospital), Abdulaziz Al‐Dawood, Sameeh Ghazal(Prince Mohammed bin Abdulaziz Hospital), M. A. Abdelzaher(Cairo University), Majed Al Jeraisy(King Saud bin Abdulaziz University for Health Sciences), Shmeylan Al Harbi(King Saud bin Abdulaziz University for Health Sciences)
Cited by 80
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k